Form 4: AngioDynamics SVP Warren Nighan JR Acquires Additional Shares

Warren Nighan JR, SVP of Quality and Regulatory at AngioDynamics Inc, reports purchasing additional shares of common stock.

Summary

• On October 7, 2024, Warren Nighan JR, SVP of Quality and Regulatory at AngioDynamics Inc, acquired 768 shares of common stock at a price of $6.09 per share.
• Following this transaction, Mr. Nighan directly owns 45,777 shares of AngioDynamics common stock.
• On October 10, 2024, Mr. Nighan acquired an additional 100 shares of common stock at a price of $6.08 per share, bringing his total direct ownership to 45,877 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock purchases by an executive, which can be interpreted as a slightly positive signal, but it's not a major event.

Positives

• The purchase of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, reporting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company executives.

Stakeholder Impact

• The purchase of shares by an executive could have a minor positive impact on shareholder sentiment.

Key Dates